Results 151 to 160 of about 26,501 (228)

Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515). [PDF]

Signal Transduct Target Ther
Xie Q, Yang Y, Xie S, Yang X, Gao F, Qi W, Liu H, Liu Y, Deng J, Liu X, Zhou Y, Zhao X, Jiang K, Mao T, Liao X, Dai R, Lyu Y, Cai Y, Xie K, Wu H, Lan T, Liu C, CHANCE2515 Investigators.   +22 more
europepmc   +1 more source

Combination of Traditional Chinese Medicine and Transarterial Chemoembolization for Hepatocellular Carcinoma: A Bibliometric Analysis. [PDF]

J Hepatocell Carcinoma
Liu X, Zhang K, Wang Z, Zheng Y, Lin L, Wang J, Pan X, Li Y.   +7 more
europepmc   +1 more source

Advances and Emerging Techniques in Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Gazda HL, Le PD, Patel A, Jha A, Makary MS.   +4 more
europepmc   +1 more source

Transarterial chemoembolization with radioactive seed implantation for multitumor hepatocellular carcinoma. [PDF]

Wideochir Inne Tech Maloinwazyjne
Gao FL, Su Z, Chen DK, Huang XZ, Ma GL.
europepmc   +1 more source

Efficacy analysis of icaritin combined with transarterial chemoembolization in hepatocellular carcinoma stratified by different child-pugh classes. [PDF]

Front Immunol
Xu J, Xing Y, Zhao F, Tang B, Li X, Cun J, Lu H, Xia X, Fan H, Gu Y, Xu T.   +10 more
europepmc   +1 more source

Local Tumor Response to Conventional Transarterial Chemoembolization following Seven-day Lenvatinib Administration. [PDF]

Interv Radiol (Higashimatsuyama)
Kageyama K, Uchida-Kobayashi S, Shinkawa H, Yamamoto A, Odagiri N, Kinoshita M, Nakano-Maebayashi M, Asano K, Fujii H, Enomoto M, Ishizawa T, Miki Y.   +11 more
europepmc   +1 more source

Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma. [PDF]

Oncol Res
Wang X, Wang S, Liang C, Wu H, Liu S, Wang J, Lu J.   +6 more
europepmc   +1 more source

Advancing risk stratification in intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization: the promise of the NTAA model. [PDF]

Hepatobiliary Surg Nutr
Kobus Z, Yarmohammadi H.
europepmc   +1 more source

Durvalumab and bevacizumab plus transarterial chemoembolization in unresectable hepatocellular carcinoma: a new paradigm? [PDF]

Transl Gastroenterol Hepatol
Abdelrahim M, Esmail A, Al-Judaibi B.
europepmc   +1 more source

Transarterial Radioembolization Versus Transarterial Chemoembolization in Elderly Patients (≥75 Years) With Hepatocellular Carcinoma: A Propensity Score-Matched Comparison. [PDF]

Korean J Radiol
Cho CY, Kim GH, Ko E, Kim J, Sung C, Kim JH, Gwon DI.   +6 more
europepmc   +1 more source